Literature DB >> 8862595

Second-generation line probe assay for hepatitis C virus genotyping.

L Stuyver1, A Wyseur, W van Arnhem, F Hernandez, G Maertens.   

Abstract

Because of the enormous variability of hepatitis C virus (HCV), the development of reliable genotyping assays is a formidable challenge. The optimal genotyping region appears to be the 5' untranslated region (UR) because of high conservation within, but considerable variability between, genotypes. In this study, 21 probes dispersed over seven variable 5' UR areas were applied to a line probe assay (LiPA) and used to analyze 506 HCV-infected sera from different geographical regions representing a multitude of subtypes. At least 31 different reactivity patterns emerged, with 404 (80%) of 506 distributed over 11 prototype patterns, in general corresponding to subtypes 1a, 1b, 2a/2c, 2b, 3a, 5a, and 6a and several type 4 subtypes. Subtyping specificity ranged from 97% in Hong Kong to 90% in Europe but was only 11% in West Africa, while typing specificity was always 100% when samples from Vietnam were excluded. In a second evaluation, the subtype prediction by LiPA of 448 GenBank 5' UR HCV sequences was scored. Of the 58 theoretically predicted patterns, 321 sequences (72%) were covered by the 11 prototype patterns. We concluded that (i) the selected probes detected the corresponding signature motifs in the seven variable regions with 100% reliability; (ii) these motifs allowed correct type interpretation of samples collected worldwide, with the exclusion of Vietnam, Thailand, or Vietnamese patients residing in European hospitals; and (iii) subtyping specificities vary according to geographical region, with 11 prototype subtyping patterns identifying the majority of samples from Europe and the Americas. These results indicate that the LiPA is a reliable assay applicable to routine typing and subtyping of HCV specimens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862595      PMCID: PMC229228          DOI: 10.1128/jcm.34.9.2259-2266.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

Authors:  D B Smith; J Mellor; L M Jarvis; F Davidson; J Kolberg; M Urdea; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

2.  A proposed system for the nomenclature of hepatitis C viral genotypes.

Authors:  P Simmonds; A Alberti; H J Alter; F Bonino; D W Bradley; C Brechot; J T Brouwer; S W Chan; K Chayama; D S Chen
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

3.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

4.  Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection.

Authors:  A Tsubota; K Chayama; K Ikeda; A Yasuji; I Koida; S Saitoh; M Hashimoto; S Iwasaki; M Kobayashi; K Hiromitsu
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

5.  Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups.

Authors:  H Tokita; H Okamoto; F Tsuda; P Song; S Nakata; T Chosa; H Iizuka; S Mishiro; Y Miyakawa; M Mayumi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

Authors:  H Okamoto; H Tokita; M Sakamoto; M Horikita; M Kojima; H Iizuka; S Mishiro
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

7.  Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.

Authors:  J B Nousbaum; S Pol; B Nalpas; P Landais; P Berthelot; C Bréchot
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

Review 8.  Genetic heterogeneity of hepatitis C virus.

Authors:  H Okamoto; S Mishiro
Journal:  Intervirology       Date:  1994       Impact factor: 1.763

9.  Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications.

Authors:  A Widell; S Shev; S Månsson; Y Y Zhang; U Foberg; G Norkrans; A Frydén; O Weiland; J Kurkus; E Nordenfelt
Journal:  J Med Virol       Date:  1994-11       Impact factor: 2.327

10.  HCV-associated liver cancer without cirrhosis.

Authors:  M S De Mitri; K Poussin; P Baccarini; P Pontisso; A D'Errico; N Simon; W Grigioni; A Alberti; M Beaugrand; E Pisi
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

View more
  85 in total

1.  Phylogenetic characterization of genotype 4 hepatitis C virus isolates from Argentina.

Authors:  V Alfonso; D Flichman; S Sookoian; V A Mbayed; R H Campos
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Distribution of HCV genotypes among risk groups in Serbia.

Authors:  G Stamenkovic; S Zerjav; Z M Velickovic; K Krtolica; V L Samardzija; L Jemuovic; D Nozic; B Dimitrijevic
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy.

Authors:  L Stuyver; C Van Geyt; S De Gendt; G Van Reybroeck; F Zoulim; G Leroux-Roels; R Rossau
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping.

Authors:  Ted E Schutzbank; Susan E Sefers; Nicole Kahmann; Haijing Li; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

6.  Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

Authors:  P Halfon; P Trimoulet; M Bourliere; H Khiri; V de Lédinghen; P Couzigou; J M Feryn; P Alcaraz; C Renou; H J Fleury; D Ouzan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 7.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

8.  Genotyping of hepatitis C virus by sequence analysis of the amplicon from the Roche Cobas AmpliPrep/Cobas TaqMan viral load assay.

Authors:  Todd S Laughlin; Bonnie Nuccie; Paul G Rothberg
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

9.  Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions.

Authors:  Elisa Martró; Victoria González; Andrew J Buckton; Verónica Saludes; Gema Fernández; Lurdes Matas; Ramón Planas; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

10.  Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.

Authors:  Sylvie Larrat; Jean-Dominique Poveda; Camille Coudret; Katia Fusillier; Nelly Magnat; Anne Signori-Schmuck; Vincent Thibault; Patrice Morand
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.